Ocean Grown Ventures was founded in 2017 by senior executives who believe in the power of medical cannabis, world-renown Israeli scientific research, and the indefatigable strength of California’s market.
There are numerous avenues for investment within the global cannabis industry. Because of the complex legal climate of cannabis in the United States, however, these investment avenues face varying degrees of risk – from ancillary services, products, and technology, to federally illegal, but state-legal and state-regulated areas. Recognizing this wide spectrum of investment opportunities, we have assembled a diversified portfolio of ancillary and direct partnerships both in the United States and Israel.
Israeli scientists are world renown for their breakthroughs in agriculture, technology, life science and software. Israel has taken this “Start-Up Nation” vigor into the cannabis industry. It was an Israeli scientist, Dr. Raphael Mechoulam, who first discovered the main components of cannabis, and because cannabis is legal in Israel, Israeli companies have the unique ability to conduct clinical trials and research studies with government approval. Comparatively, the United States has restricted and virtually banned rigorous scientific research and applications of cannabis because cannabis remains a schedule I controlled substance under the federal Controlled Substance Act – these limitations leverage our Israeli partners to be innovative first movers with a barrier to entry virtually insurmountable in the US.
We bring unmatched innovators, products, and technology from Israel to the US, and continue to form new relationships and partnerships with top players in the industry in the US and beyond – see our portfolio for more details.